Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.

PURPOSE To retrospectively investigate treatment outcomes of stereotactic ablative body radiation therapy (SABR) for octogenarians with non-small cell lung cancer (NSCLC). METHODS AND MATERIALS Between 2005 and 2012, 109 patients aged ≥80 years with T1-2N0M0 NSCLC were treated with SABR: 47 patients had histology-unproven lung cancer; 62 patients had pathologically proven NSCLC. The prescribed doses were either 50 Gy/5 fractions for peripheral tumors or 40 Gy/5 fractions for centrally located tumors. The treatment outcomes, toxicities, and the correlating factors for overall survival (OS) were evaluated. RESULTS The median follow-up duration after SABR was 24.2 (range, 3.0-64.6) months. Only limited toxicities were observed, except for 1 grade 5 radiation pneumonitis. The 3-year local, regional, and distant metastasis-free survival rates were 82.3%, 90.1%, and 76.8%, respectively. The OS and lung cancer-specific survival rates were 53.7% and 70.8%, respectively. Multivariate analysis revealed that medically inoperable, low body mass index, high T stage, and high C-reactive protein were the predictors for short OS. The OS for the operable octogenarians was significantly better than that for inoperable (P<.01). CONCLUSIONS Stereotactic ablative body radiation therapy for octogenarians was feasible, with excellent OS. Multivariate analysis revealed that operability was one of the predictors for OS. For medically operable octogenarians with early-stage NSCLC, SABR should be prospectively compared with resection.

[1]  D. Sugarbaker,et al.  Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. , 2005, Chest.

[2]  K. Haeussinger,et al.  Radical systematic mediastinal lymphadenectomy in non‐small cell lung cancer: A randomized controlled trial , 1994, The British journal of surgery.

[3]  E. Kunieda,et al.  Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. , 2012, Lung cancer.

[4]  J. Sonke,et al.  A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  J. Luketich,et al.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. , 2006, The Annals of thoracic surgery.

[6]  E. Beattie,et al.  Surgical treatment of non‐small cell lung cancer in patients older than seventy years , 1995, Journal of surgical oncology.

[7]  K. Yasumoto,et al.  Results of surgical treatment of lung cancer in octogenarians. , 1999, Lung cancer.

[8]  M. Berry,et al.  A model for morbidity after lung resection in octogenarians. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  E. Kunieda,et al.  Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy. , 2012, Chest.

[10]  J. Bradley,et al.  A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. , 2012, The Journal of thoracic and cardiovascular surgery.

[11]  P. Pairolero,et al.  Lung cancer in octogenarians: factors affecting long-term survival following resection. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  Zhongxing Liao,et al.  Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  H. Shirato,et al.  Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. , 2009, International journal of radiation oncology, biology, physics.

[14]  E. Miyaoka,et al.  Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  Jose Belderbos,et al.  Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  N. Aaronson,et al.  Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  L. Spaggiari,et al.  Surgery of non-small cell lung cancer in the elderly , 2007, Current opinion in oncology.

[18]  R. V. van Klaveren,et al.  Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. , 2010, Lung cancer.

[19]  S. Senan,et al.  Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. , 2010, Cancer.

[20]  E. Kunieda,et al.  Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. , 2009, International journal of radiation oncology, biology, physics.